Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - Other
Ratios

Spero Therapeutics (SPRO) Preferred Shares Issued (2017 - 2020)

Spero Therapeutics (SPRO) has disclosed Preferred Shares Issued for 2 consecutive years, with $9.8 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Preferred Shares Issued changed N/A year-over-year to $9.8 million, compared with a TTM value of $30.4 million through Dec 2020, changed N/A, and an annual FY2020 reading of $30.4 million, changed N/A over the prior year.
  • Preferred Shares Issued was $9.8 million for Q4 2020 at Spero Therapeutics, down from $20.6 million in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $43.0 million in Q1 2017 and bottomed at $1000.0 in Q2 2017.